Works matching AU Dal Pino, Beatrice
Results: 32
PCSK9 Inhibitors' New Users: Analysis of Prescription Patterns and Patients' Characteristics from an Italian Real-world Study.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 2, p. 173, doi. 10.1007/s40261-019-00877-3
- By:
- Publication type:
- Article
Lipoprotein(a), Cardiovascular Events and Sex Differences: A Single Cardiological Unit Experience.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 3, p. 764, doi. 10.3390/jcm12030764
- By:
- Publication type:
- Article
Direct oral anticoagulants in lipoprotein apheresis: handle with care.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Coronary microcirculatory blood flow significantly increases upon acute and chronic cholesterol lowering: evaluation by cadmium–zinc–telluride cardiac imaging stress test.
- Published in:
- European Journal of Preventive Cardiology, 2022, v. 29, n. 8, p. e272, doi. 10.1093/eurjpc/zwac043
- By:
- Publication type:
- Article
Acute effect of lipoprotein apheresis on coronary flow velocity reserve evaluated by the cold pressure test.
- Published in:
- European Journal of Preventive Cardiology, 2021, v. 28, n. 8, p. e4, doi. 10.1177/2047487320931622
- By:
- Publication type:
- Article
Inherited atherogenic dyslipidemias: are they correctly reported?
- Published in:
- European Journal of Preventive Cardiology, 2021, v. 28, n. 8, p. e1, doi. 10.1177/2047487320930308
- By:
- Publication type:
- Article
A large Italian cohort on proprotein convertase subtilisin/kexin type 9 inhibitors.
- Published in:
- European Journal of Preventive Cardiology, 2020, v. 27, n. 19, p. 2284, doi. 10.1177/2047487319888059
- By:
- Publication type:
- Article
HeFH in real life, how to: More evolocumab than authorized.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Null receptor homozygous familial hypercholesterolaemia: Quoad valetudinem long life treatment.
- Published in:
- European Journal of Preventive Cardiology, 2020, v. 27, n. 19, p. 2105, doi. 10.1177/2047487319864191
- By:
- Publication type:
- Article
Recent TakoTsubo syndrome and lipoprotein apheresis: An alert for a safe procedure.
- Published in:
- European Journal of Preventive Cardiology, 2020, v. 27, n. 4, p. 444, doi. 10.1177/2047487319835635
- By:
- Publication type:
- Article
Effect of proprotein convertase subtilisin/kexin type 9 inhibitors on lipoprotein(a) still to be unravelled.
- Published in:
- European Journal of Preventive Cardiology, 2019, v. 26, n. 7, p. 782, doi. 10.1177/2047487319825918
- By:
- Publication type:
- Article
Heterozygous familial hypercholesterolemia and HIV infection: The appropriate therapeutic flow chart is still to be written?
- Published in:
- 2018
- By:
- Publication type:
- Letter
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else?
- Published in:
- European Journal of Preventive Cardiology, 2017, v. 24, n. 14, p. 1528, doi. 10.1177/2047487317712419
- By:
- Publication type:
- Article
Fenofibrate in Lipoprotein Glomerulopathy: A 20-Year Long Resolution.
- Published in:
- 2025
- By:
- Publication type:
- Letter
Inclisiran and lipoprotein apheresis in statin intolerance heterozygous FH patients: A case series.
- Published in:
- Therapeutic Apheresis & Dialysis, 2023, v. 27, n. 5, p. 978, doi. 10.1111/1744-9987.14025
- By:
- Publication type:
- Article
Skin microcirculation significantly increases after lipoprotein apheresis.
- Published in:
- Therapeutic Apheresis & Dialysis, 2023, v. 27, n. 4, p. 823, doi. 10.1111/1744-9987.13976
- By:
- Publication type:
- Article
Elusive Therapeutic Effect of PCSK9 Inhibitors on Lipoprotein(a) Levels.
- Published in:
- Therapeutic Apheresis & Dialysis, 2019, v. 23, n. 4, p. 385, doi. 10.1111/1744-9987.12766
- By:
- Publication type:
- Article
Therapeutic adherence in patients treated with PCSK9i: focus on skin side effects.
- Published in:
- Acta Cardiologica, 2024, v. 79, n. 5, p. 625, doi. 10.1080/00015385.2024.2310931
- By:
- Publication type:
- Article
Patients with diabetes mellitus and atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants.
- Published in:
- Acta Cardiologica, 2022, v. 77, n. 6, p. 565, doi. 10.1080/00015385.2021.1962623
- By:
- Publication type:
- Article
Familial LCAT deficiency and cardiovascular disease: the game is not over A case of dramatic multivessel atherosclerosis.
- Published in:
- Minerva Medica, 2023, v. 114, n. 4, p. 535, doi. 10.23736/S0026-4806.20.06633-1
- By:
- Publication type:
- Article
Women and lipoprotein apheresis: another side of gender medicine.
- Published in:
- Endocrine (1355008X), 2024, v. 86, n. 3, p. 954, doi. 10.1007/s12020-024-03941-x
- By:
- Publication type:
- Article
Male fertility and high cholesterol: to treat or not to treat?
- Published in:
- 2024
- By:
- Publication type:
- Letter
"Eve is not Adam" – differences in efficacy, safety and clinical outcomes with lipoprotein apheresis between sexes.
- Published in:
- Endocrine (1355008X), 2024, v. 85, n. 1, p. 233, doi. 10.1007/s12020-024-03742-2
- By:
- Publication type:
- Article
Lipoprotein (a): epidemiology, pathophysiology, measurement issues and clinical management.
- Published in:
- Biochimica Clinica, 2024, v. 48, n. 1, p. 7, doi. 10.19186/BC_2024.001
- By:
- Publication type:
- Article
Comorbidity in lipoprotein apheresis: Their role in the era of new lipid‐lowering therapies.
- Published in:
- Journal of Clinical Apheresis, 2024, v. 39, n. 1, p. 1, doi. 10.1002/jca.22094
- By:
- Publication type:
- Article
Comment on "Homozygous familial hypercholesterolemia with severe involvement of the aortic valve: A sibling‐controlled case study on the efficacy of lipoprotein apheresis".
- Published in:
- Journal of Clinical Apheresis, 2021, v. 36, n. 1, p. 219, doi. 10.1002/jca.21834
- By:
- Publication type:
- Article
COVID‐19 swab collection and serological screening in lipoprotein apheresis unit.
- Published in:
- Journal of Clinical Apheresis, 2020, v. 35, n. 4, p. 382, doi. 10.1002/jca.21810
- By:
- Publication type:
- Article
Gastroprotection during long-term dual antiplatelet therapy: to give or not to give?
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: is there a role for fibrates?
- Published in:
- European Journal of Preventive Cardiology, 2024, v. 31, n. 15, p. e111, doi. 10.1093/eurjpc/zwae247
- By:
- Publication type:
- Article
Lipoprotein apheresis reduces major adverse cardiovascular event incidence in high-lipoprotein (a) subjects on proprotein convertase subtilisin/kexin type 9 inhibitor therapy.
- Published in:
- European Journal of Preventive Cardiology, 2024, v. 31, n. 8, p. e62, doi. 10.1093/eurjpc/zwae054
- By:
- Publication type:
- Article
HDL and clinical and biochemical correlates in Italian non-smoker women.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2004, v. 42, n. 12, p. 1408, doi. 10.1515/CCLM.2004.262
- By:
- Publication type:
- Article
Vascular access in lipoprotein apheresis: Save the vein save the life.
- Published in:
- 2021
- By:
- Publication type:
- Letter